Key Points
- CEO James Matthew Darden sold 4,663 shares on April 28 at an average price of $153.88 for about $717,542, leaving him with 58,451 shares (a 7.39% reduction valued near $8.99M).
- He also executed sizable insider sales earlier this year—18,318 shares on March 4 (~$2.66M) and 9,527 shares on February 27 (~$1.38M)—indicating continued insider selling this quarter.
- Globe Life missed Q1 EPS by $0.03 ($3.43 vs. $3.46), set FY2026 guidance of 15.40–15.90 EPS (consensus ~15.45), and raised its quarterly dividend to $0.33 from $0.27 (annualized $1.32, ~0.9% yield).
Globe Life Inc. (NYSE:GL - Get Free Report) CEO James Matthew Darden sold 4,663 shares of the business's stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the sale, the chief executive officer owned 58,451 shares in the company, valued at approximately $8,994,439.88. The trade was a 7.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
James Matthew Darden also recently made the following trade(s):
- On Wednesday, March 4th, James Matthew Darden sold 18,318 shares of Globe Life stock. The stock was sold at an average price of $145.10, for a total value of $2,657,941.80.
- On Friday, February 27th, James Matthew Darden sold 9,527 shares of Globe Life stock. The stock was sold at an average price of $144.34, for a total value of $1,375,127.18.
Globe Life Price Performance
Shares of NYSE GL opened at $152.38 on Thursday. The business's 50 day moving average price is $144.12 and its 200 day moving average price is $139.88. The firm has a market cap of $11.95 billion, a P/E ratio of 10.54 and a beta of 0.47. Globe Life Inc. has a 52 week low of $111.13 and a 52 week high of $155.08. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.39.
Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 21.30% and a net margin of 19.38%.The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the company posted $3.07 EPS. Globe Life's quarterly revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, sell-side analysts expect that Globe Life Inc. will post 15.45 earnings per share for the current year.
Globe Life Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be paid a $0.33 dividend. The ex-dividend date is Thursday, April 2nd. This is an increase from Globe Life's previous quarterly dividend of $0.27. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. Globe Life's dividend payout ratio (DPR) is currently 9.13%.
Institutional Trading of Globe Life
Hedge funds have recently added to or reduced their stakes in the company. Mather Group LLC. acquired a new stake in Globe Life during the third quarter valued at $28,000. Hilton Head Capital Partners LLC acquired a new position in shares of Globe Life in the fourth quarter worth about $30,000. CYBER HORNET ETFs LLC acquired a new position in shares of Globe Life in the second quarter worth about $28,000. MUFG Securities EMEA plc purchased a new stake in shares of Globe Life during the 2nd quarter worth about $31,000. Finally, Quent Capital LLC purchased a new stake in shares of Globe Life during the 3rd quarter worth about $36,000. 81.61% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. Wells Fargo & Company boosted their target price on shares of Globe Life from $171.00 to $172.00 and gave the company an "overweight" rating in a research report on Friday, April 10th. Weiss Ratings lowered Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research note on Monday. Truist Financial boosted their price objective on Globe Life from $180.00 to $185.00 and gave the company a "buy" rating in a report on Friday, April 24th. Texas Capital upgraded Globe Life to a "strong-buy" rating in a research note on Wednesday, March 18th. Finally, Piper Sandler raised Globe Life to a "strong-buy" rating in a report on Thursday, April 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $172.67.
Check Out Our Latest Analysis on GL
About Globe Life
(
Get Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
